Novel composition comprising rosiglitazone and another...

Details Novel composition comprising rosiglitazone and another... Novel composition comprising rosiglitazone and another...

A - Human Necessities

61

K

A61K 31/155 (2006.01) A61K 9/28 (2006.01) A61K 31/4439 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2534480

An oral dosage form comprising an erodable core, which core comprises rosiglitazone or a pharmaceutically acceptable salt or solvate thereof and another antidiabetic agent, the core having a coating with one or more openings, characterised in that the coating is erodable under predetermined pH conditions; a process for preparing such a dosage form and the use of such a dosage form in medicine.

L'invention concerne une forme orale dosifiée comprenant un noyau érodable qui comprend la rosiglitazone ou un sel ou un solvate de celle-ci pharmaceutiquement acceptable et un autre agent antidiabétique. Ledit noyau comprenant un enrobage doté d'une ou plusieurs ouverture(s) est caractérisé en ce que ledit noyau est érodable dans des conditions de pH prédéterminées. L'invention concerne également un procédé permettant de préparer ladite forme dosifiée et d'utiliser cette forme dosifiée en médecine.

Affiliated with

Also associated with

Rating

Novel composition comprising rosiglitazone and another... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel composition comprising rosiglitazone and another..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel composition comprising rosiglitazone and another... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1957609